FDA OKs Second Trial to Test Effects of Stem-cell Infusions

FDA OKs Second Trial to Test Effects of Stem-cell Infusions

297454

FDA OKs Second Trial to Test Effects of Stem-cell Infusions

The U.S. Food and Drug Administration (FDA) has approved a Phase 3 trial to test multiple infusions of fat-derived mesenchymal stem cells — ones obtained from healthy donors — in people with Parkinson’s disease. The Hope Biosciences Stem Cell Research Foundation (HBSCRF), which received the authorization, already has a similar study underway that is examining the efficacy of such infusions using patients’ own fat-derived mesenchymal stem cells. That Phase 2 study (NCT04928287) — which is…

You must be logged in to read/download the full post.